Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer

BACKGROUND: Mutations in rat sarcoma (RAS) genes may be a mechanism of secondary resistance in epidermal growth factor receptor inhibitor-treated patients. Tumor-tissue biopsy testing has been the standard for evaluating mutational status; however, plasma testing of cell-free DNA has been shown to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Siena, S, Sartore-Bianchi, A, Garcia-Carbonero, R, Karthaus, M, Smith, D, Tabernero, J, Van Cutsem, E, Guan, X, Boedigheimer, M, Ang, A, Twomey, B, Bach, B A, Jung, A S, Bardelli, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834114/
https://www.ncbi.nlm.nih.gov/pubmed/28945848
http://dx.doi.org/10.1093/annonc/mdx504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834114/
https://www.ncbi.nlm.nih.gov/pubmed/28945848
http://dx.doi.org/10.1093/annonc/mdx504

Ejemplares similares